Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG. Issue 1 (2nd January 2023) - Othus, Megan; Thomas, Ian; Wang, Xu; Ariti, Cono; Mehta, Priyanka; Sydenham, Mia; Hills, Robert K.; Burnett, Alan K.; Nand, Sucha; Assouline, Sarit; Michaelis, Laura C.; Erba, Harry P.; et al.